Ipca Laboratories Limited (BOM:524494)
India · Delayed Price · Currency is INR 1,939.15
-7.00 (-0.36%)
At close: Oct 7, 2026
Ipca Laboratories Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, Ipca Laboratories stock has a consensus rating of "Strong Buy" and an average price target of ₹1,982. The average 1-year stock price forecast is 2.20% higher than the current stock price, while the lowest is ₹1,731 (-10.73%) and the highest is ₹2,230 (+15.00%).
Price Target: ₹1,982 (+2.20%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Ipca Laboratories stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 10 | 10 | 11 | 11 |
| Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Hold | 2 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Total | 17 | 16 | 17 | 17 | 17 | 17 |
Financial Forecast
Revenue This Year
109.99B
from 96.47B
Increased by 14.01%
Revenue Next Year
122.75B
from 109.99B
Increased by 11.60%
EPS This Year
59.98
from 46.94
Increased by 27.79%
EPS Next Year
70.40
from 59.98
Increased by 17.37%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.